Chloroquine for COVID-19 infection
| dc.creator | Moore, Nicholas | |
| dc.date.accessioned | 2020-04-07T20:00:29Z | |
| dc.date.available | 2020-04-07T20:00:29Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Indisponível. | pt_BR |
| dc.description.resumo | Indisponível. | pt_BR |
| dc.identifier.citation | MOORE, N. Chloroquine for COVID-19 infection. Drug Safety, [S.l.], 2020. | pt_BR |
| dc.identifier.uri | https://repositorio.ufla.br/handle/1/39872 | |
| dc.identifier.uri | https://link.springer.com/article/10.1007/s40264-020-00933-4 | pt_BR |
| dc.language | en_US | pt_BR |
| dc.publisher | Springer | pt_BR |
| dc.rights | openAccess | pt_BR |
| dc.source | Drug Safety | pt_BR |
| dc.subject | COVID 19 | pt_BR |
| dc.subject | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | pt_BR |
| dc.subject | Chloroquine | pt_BR |
| dc.subject | Raoult, Didier | pt_BR |
| dc.title | Chloroquine for COVID-19 infection | pt_BR |
| dc.type | Artigo | pt_BR |
Arquivos
Licença do pacote
1 - 1 de 1
Carregando...
- Nome:
- license.txt
- Tamanho:
- 953 B
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
